RES-020

N/A

Report date: 2025/09/04 15:44:16
NME

Base Information

Drug NameRES-020
Drug Alias NameGaINAc conjugated RES-010RES-020
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionmicroRNA-22 modulatorsAsialoglycoprotein receptor modulators
TargetsmicroRNA-22Asialoglycoprotein receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesResalis Therapeutics SRL
China Registration ClassN/A

Develop Information

Active CompaniesResalis Therapeutics SRL
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A